Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 30
Filtrar
Más filtros

País/Región como asunto
País de afiliación
Intervalo de año de publicación
1.
Gac Med Mex ; 151(2): 169-75, 2015.
Artículo en Español | MEDLINE | ID: mdl-25946527

RESUMEN

INTRODUCTION: Psychosis associated with Parkinson's disease is a major neuropsychiatric complication; it has been reported that 60% of patients will develop psychosis during the disease evolution. Its pathophysiology is multifactorial and clinically psychotic phenomena include minor hallucinations and confusional states. MATERIAL AND METHODS: We performed a cross-sectional study in patients with Parkinson's disease from a tertiary hospital using a thoughtful neurological and neuropsychiatric evaluation along with specific scales for non-motor symptoms, depression, cognition, and presence and severity of psychotic symptoms and hallucinations. RESULTS: We included a total of 236 patients with Parkinson's disease, of which 33 (13.9%) patients met the criteria for psychosis at the time of the evaluation. Visual hallucinations were the most common symptom. Age (p = 0.004), age at onset of the disease (p = 0.007) and its duration (p = 0.004), use of levodopa (p = 0.02), and use of amantadine (p = 0.004) were the main factors associated with the presence of psychosis. CONCLUSION: Psychosis in Parkinson's disease is a relatively common manifestation and is mainly associated with clinical and demographic factors. Early recognition will optimize management and improve the quality of life of patients and their caregivers.


Asunto(s)
Enfermedad de Parkinson/complicaciones , Trastornos Psicóticos/etiología , Anciano , Estudios Transversales , Femenino , Humanos , Masculino , Persona de Mediana Edad , Enfermedad de Parkinson/psicología , Prevalencia
2.
Gac Med Mex ; 150(4): 362-6, 2014.
Artículo en Español | MEDLINE | ID: mdl-25098223

RESUMEN

The life of Vincent van Gogh (1853-1890) has been studied thoroughly by humanists and scientists alike. His biography is an archetype of the relationship between creativity and disease. In 1956, Henri Gastaut defined his diagnosis as temporal lobe epilepsy. The artist was known for an eccentric personality and unpredictable mood, with recurrent psychotic bouts through the last two years of his life. Several authors have considered the possibility that van Gogh also suffered from bipolar affective disorder. We conducted a biographical and epistolary review with the objective of analyzing the complexity of his disease and the effects it had on his art, which ultimately placed him as one of the greatest geniuses in art.


Asunto(s)
Creatividad , Neuropsiquiatría , Pinturas , Historia del Siglo XIX , Países Bajos
3.
Cureus ; 14(4): e24467, 2022 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-35637821

RESUMEN

Background and objective Alternative chemotherapy regimens, including cisplatin, carmustine, or other agents, have been shown to be effective; however, the use of carboplatin plus vincristine (C/V) has not been studied before. In this study, we aimed to determine the survival rates in patients treated with C/V, by comparing our findings with treatments based on temozolomide (TMZ), and to explore a possible relationship with the methylation status of the methylguanine methyltransferase (MGMT) promoter in patients with glioblastoma (GB). Methods A retrospective cohort study was conducted involving 45 surgically treated patients diagnosed with GB. Fresh tissue samples were examined by the DNA bisulfite conversion method to determine methylation status. After surgery, different chemotherapy regimens were employed as adjuvants. Follow-up of participants was performed as outpatients at three-month intervals to determine overall survival (OS), by comparing the use of TMZ versus C/V. Results MGMT promoter methylation status could only be determined in 35 samples; 20 patients received adjuvant chemotherapy, of which 14 were treated with C/V and six with TMZ-based schemes. The median OS (mOS) was eight months (range: 1-24 months). OS was 57.25% at six months, 48.7% at 12 months, and 28.5% at 24 months. In the TMZ group, an OS of 83% was observed at 24 months. In the C/V group, OS was 71.4% at six months, 57.1% at 12 months, and 35.7% at 24 months. Patients who did not receive adjuvant chemotherapy treatment had the lowest survival rates with an OS of 39.9% at six months, 26.6% at 12 months, and 19.9% ​​at 24 months. Conclusions Based on our findings, C/V offers an accessible and effective alternative treatment when the TMZ-based scheme is not accessible, providing higher rates of OS compared to patients without chemotherapy management. The methylation status of the MGMT promoter is a significant prognostic factor, resulting in higher survival rates among patients when it is methylated.

5.
Mult Scler Relat Disord ; 52: 102967, 2021 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-33934010

RESUMEN

INTRODUCTION: Multiple sclerosis (MS) is a chronic neurological autoimmune condition and the leading non-traumatic cause of neurological disability worldwide. Disease-modifying therapies (DMT) directly impact on the long-term prognosis of patients with MS preventing relapses and the associated disability progression. Here, we analyzed the impact of socioeconomic status (SES) on DMT access in Mexican patients. METHODS: We evaluated the association between SES and DMT access using the MS registry from the National Institute of Neurology and Neurosurgery in Mexico City. We included 974 patients with MS (McDonald 2010 criteria). We categorized SES according to the 2018 Mexican Association of Market Research Agencies (AMAI) SES classification. We analyzed DMT type, MS phenotype, educational level, symptomatic onset to diagnosis, EDSS at arrival, as well as the progression index. Chi-squared and Wilcoxon tests were used, and multivariable analysis performed for DMT access. RESULTS: When comparing the lower versus higher levels of SES, a significant association was found on the percentage of patients with higher levels of disability (EDSS >6) at arrival, the proportion of patients not receiving any DMT and a higher proportion of secondary progressive MS (p=0.006, p<0.001and p=0.004, respectively). We also found that lower educational levels had a significance and inverse association with EDSS on first visit (p=0.019), symptomatic onset to diagnosis (p<0.001) and a higher disability status at arrival (EDSS >6, p=0.010). CONCLUSIONS: Our study suggests that SES is an important factor determining not only prompt but overall access to highly effective DMT. Lower SES are associated with greater levels of disability at the first clinic visit and a higher proportion of patients not receiving DMT up to 12 months of follow-up.


Asunto(s)
Esclerosis Múltiple Crónica Progresiva , Esclerosis Múltiple , Humanos , México , Recurrencia , Clase Social
6.
Clin Neurol Neurosurg ; 196: 106007, 2020 09.
Artículo en Inglés | MEDLINE | ID: mdl-32559706

RESUMEN

OBJECTIVES: The aim of the present study is to explore the efficacy of rituximab in patients with Neuromyelitis Optica spectrum disorders (NMOsd) with positive AQP4-IgG serostatus. PATIENTS AND METHODS: In this single center retrospective study, we recruited seropositive anti-AQP4 NMOsd patients who received treatment with Rituximab (RTX) for at least 2 years. Demographics were described and annualized relapse rate (AAR) and survival analysis were performed for time to relapse with Rituximab. All p values ≤0.05 we considered statistically significant. RESULTS: A total of 15 patients (100 % female) were identified. Mean age of disease onset was 34 ±â€¯11 years, mean time of disease was 8.11 ±â€¯4.04 years and the median number of relapses was 5 (2-16). Ten patients received an immunosuppressive agent before RTX. Mean age of RTX initiation was 37 ±â€¯12 with a mean treatment duration of 52 ±â€¯28 months. The median ARR before and after treatment with RTX was 2.08 vs 0.00, respectively, with a difference of -2.08 (p < 0.001) CONCLUSIONS: This study shows a statistically significant reduction in the ARR and an increase in the relapse-free rate in AQP4-IgG NMOsd patients treated with RTX. These findings support the use of rituximab in our population, and indirectly suggests that its prompt use could modify the course of the disease.


Asunto(s)
Acuaporina 4/inmunología , Factores Inmunológicos/uso terapéutico , Neuromielitis Óptica/tratamiento farmacológico , Rituximab/uso terapéutico , Adulto , Femenino , Humanos , América Latina , Masculino , Persona de Mediana Edad , Neuromielitis Óptica/inmunología , Estudios Retrospectivos , Resultado del Tratamiento , Adulto Joven
7.
Gac Med Mex ; 145(1): 71-6, 2009.
Artículo en Español | MEDLINE | ID: mdl-19256415

RESUMEN

The participation of women in higher education in Mexico took place in the late 19th and early 20th century. The rise of women's enrollment in universities known as the "feminization of enrollment" occurred in the last thirty years. In this review we analyze how the new conditions that facilitated better access to higher education are reflected in the inclusion of women in science. We include an overview of the issues associated with a change in the demographics of enrollment, segregation of academic areas between men and women and participation in post graduate degrees. We also review the proportion of women in science. While in higher education the ratio between male and women is almost 50-50 and in some areas the presence of women is even higher, in the field of scientific research women account for barely 30% of professionals. This is largely due to structural conditions that limit the access of women to higher positions of power that have been predominantly taken by men.


Asunto(s)
Ciencia/educación , Ciencia/historia , Mujeres/educación , Mujeres/historia , Historia del Siglo XIX , Historia del Siglo XX , México
8.
Arch Med Res ; 50(3): 111-112, 2019 04.
Artículo en Inglés | MEDLINE | ID: mdl-31495387

RESUMEN

Long-term exposure to air pollution has been linked with the development of neurodegenerative diseases. The proposed mechanisms include neuroinflammation and brain oxidative stress. Multiple sclerosis (MS) is a neurodegenerative disease with an auto-immune physiopathology and some studies have associated it with long-term exposure to airborne particulate matter. In this opinion we discuss the current body of knowledge regarding air pollution and the risk of MS as well as MS relapses. Also, its relevance in the case of Mexico City is discussed.


Asunto(s)
Contaminantes Atmosféricos/toxicidad , Contaminación del Aire/efectos adversos , Esclerosis Múltiple/inducido químicamente , Enfermedades Neurodegenerativas/inducido químicamente , Material Particulado/toxicidad , Contaminantes Atmosféricos/análisis , Encéfalo/patología , Exposición a Riesgos Ambientales , Humanos , México/epidemiología , Esclerosis Múltiple/epidemiología , Material Particulado/análisis , Recurrencia
9.
Arch Med Res ; 48(1): 113-120, 2017 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-28577864

RESUMEN

BACKGROUND: The rate at which disability progresses in multiple sclerosis (MS), and its severity, have been associated with modifiable lifestyle habits. OBJECTIVE: To investigate the risk of disability progression in MS patients according to tobacco and alcohol consumption and to the presence of overweight. METHODS: This was a follow-up of MS cases from a concluded case-control study (National Institute of Neurology and Neurosurgery, Mexico 2010-2013). The evolution in EDSS (Expanded Disability Scale Score) units was followed through a medical record review. Kaplan Meier statistics and multivariate Cox regression analysis were performed. RESULTS: Of 181 cases, 63.5% were women and 82.5% had relapsing remitting MS. Study duration was 19.95 ± 15.24 months. The disease progressed faster in daily smokers than in non-smokers (p = 0.0168). In overweight patients, disability progressed faster than in normal weight patients (p = 0.0249). Ex-consumers of alcohol had lower risk of progression than current consumers (HR = 0.33 CI 95% = 0.14-0.83, p = 0.019) and both daily and ex-smokers presented higher risk of progression than non-smokers (HR = 2.32 CI 95% = 1.14-4.72, p = 0.020 and HR = 3.56, CI 95% = 1.21-10.46, p = 0.021). Stratifying by gender, the effects of smoking and overweight were only found in men. CONCLUSIONS: Smoking is associated with rapid disability progression in MS. Our results suggest that cessation of tobacco and alcohol consumption could be clinically beneficial. Although there is association between overweight and disability progression in men, a further exploration of gender differences is necessary to corroborate this finding.


Asunto(s)
Consumo de Bebidas Alcohólicas/efectos adversos , Esclerosis Múltiple/fisiopatología , Sobrepeso/complicaciones , Fumar/efectos adversos , Adulto , Estudios de Casos y Controles , Progresión de la Enfermedad , Femenino , Humanos , Estilo de Vida , Masculino , Esclerosis Múltiple/complicaciones , Esclerosis Múltiple Recurrente-Remitente/complicaciones , Esclerosis Múltiple Recurrente-Remitente/fisiopatología
10.
Clin Neurol Neurosurg ; 146: 116-22, 2016 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-27208871

RESUMEN

OBJECTIVE: To explore the clinical prognostic factors for adults affected with astrocytoma. PATIENTS AND METHODS: Using a historic cohort, we selected 155 clinical files from patients with astrocytoma using simple randomization. The main outcome variable was overall survival time. To identify clinical prognostic factors, we used bivariate analysis, Kaplan Meier, the log rank test and the Cox regression models. The number of lost years lived with disability (DALY) based on prevalence, was calculated. RESULTS: The mean age at diagnosis was 45.7 years. Analysis according to tumour stage, including grades II, III and IV, also showed a younger age of presentation. Kaplan-Meier survival estimates showed that tumour grade, Karnofsky status (KPS) ≥70, resection type, chemotherapy, radiotherapy, alcohol consumption, familial history of cancer and clinical presentation were significantly associated with survival time. Using a proportional hazard model, age, grade IV, resection, chemotherapy+radiotherapy and KPS were identified as prognostic factors.The amount of life lost due to premature death in this population was 28 years. CONCLUSION: In our study, astrocytoma was diagnosed in young adults. The overall survival was 15 months, 9% (n=14) of patients presented a survival of 2 years, and 3% of patients survived 3 years. On average the number of years lost due to premature death and disability was 28.53 years.


Asunto(s)
Astrocitoma/epidemiología , Neoplasias Encefálicas/epidemiología , Adulto , Anciano , Astrocitoma/mortalidad , Neoplasias Encefálicas/mortalidad , Estudios de Cohortes , Femenino , Humanos , Masculino , México/epidemiología , Persona de Mediana Edad
12.
AJNR Am J Neuroradiol ; 24(7): 1386-9, 2003 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-12917134

RESUMEN

Cases of sellar involvement of neurocysticercosis (NCC) are rare. Little is known about the mechanisms by which the parasite can compromise the pituitary gland. Although NCC damages sellar structures with direct compression by large cysts, extension through the basal cisterns and third ventricle with focal arachnoiditis can result as an inflammatory response. Evaluation for hypophyseal lesions in patients with NCC may allow for the diagnosis of unexplained loss of visual acuity and hormonal disturbances.


Asunto(s)
Imagen por Resonancia Magnética , Neurocisticercosis/diagnóstico , Silla Turca/diagnóstico por imagen , Silla Turca/patología , Adulto , Diagnóstico Diferencial , Femenino , Humanos , Masculino , Persona de Mediana Edad , Neurocisticercosis/líquido cefalorraquídeo , Quiasma Óptico/diagnóstico por imagen , Quiasma Óptico/patología , Silla Turca/inervación , Seno Esfenoidal/diagnóstico por imagen , Seno Esfenoidal/inervación , Seno Esfenoidal/patología , Tomografía Computarizada por Rayos X
13.
Gac Med Mex ; 138(6): 533-46, 2002.
Artículo en Español | MEDLINE | ID: mdl-12532618

RESUMEN

Neurologic diseases have important social and economic repercussions. The economic cost related to medications, caretakers, and therapists is evident, as well as the impact the disease may cause on the family. Epilepsy is the most frequent cause of medical care at the out-patient service of the Manuel Velasco Suárez National Institute of Neurology and Neurosurgery (NINN), in Mexico City and the estimated annual prevalence of this disease is 5.9 per 1,000 inhabitants. Parkinson's disease, the most representative of movement disorders, affects 20% of the populating aged > 65 years. Depression and dementia are complex and heterogeneous neuropsychiatry disorders, representing the fifth cause of morbility after accidents, cardiovascular disease, liver cirrhosis and diabetes mellitus. During the last decades, encephalic trauma has been the first cause of mortality: among brain tumors, glioblastomas have the greatest impact. Among infectious disease of the central nervous system (CNS), which are relatively infrequent as compared to gastrointestinal or respiratory infections; viral encephalitis, AIDS-associated toxoplasmosis, and tuberculous meningitis are the most frequent discharge diagnoses at the NINN. The need for a national registration system of neurologic diseases is unquestionable. Such a system would provide accurate data regarding the magnitude of problems related with such disease and help design adequate care and prevention programs.


Asunto(s)
Enfermedades del Sistema Nervioso , Infecciones del Sistema Nervioso Central , Costo de Enfermedad , Demencia , Trastorno Depresivo , Humanos , Neoplasias del Sistema Nervioso , Traumatismos del Sistema Nervioso
16.
Psychiatry Clin Neurosci ; 59(6): 739-42, 2005 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-16401253

RESUMEN

Severe impulsiveness in the absence of apparent neurological signs has rarely been reported as a clinical presentation of multiple sclerosis (MS). An 11-year-old female developed progressive and sustained personality disturbances including disinhibition, hypersexuality, drug abuse, aggressiveness and suicide attempts, without neurological signs. She was given several unsuccessful psychopharmacological and psychotherapeutic interventions. At age 21, a diagnosis of MS was made, confirmed by imaging, laboratory and neurophysiological studies. Although unusual, MS may produce pure neurobehavioral disturbances. In the present case, widespread demyelinization produced a complex behavioral disorder, with features compatible with orbitofrontal and Klüver-Bucy syndromes.


Asunto(s)
Conducta Impulsiva/psicología , Esclerosis Múltiple/psicología , Adolescente , Adulto , Antimaníacos/uso terapéutico , Antipsicóticos/uso terapéutico , Niño , Clozapina/uso terapéutico , Femenino , Homicidio/psicología , Humanos , Conducta Impulsiva/tratamiento farmacológico , Conducta Impulsiva/etiología , Imagen por Resonancia Magnética , Masturbación , Esclerosis Múltiple/patología , Personalidad , Psicotrópicos/uso terapéutico , Trabajo Sexual , Conducta Sexual , Trastornos Relacionados con Sustancias/psicología , Suicidio/psicología , Ácido Valproico/uso terapéutico
17.
Gac. méd. Méx ; 145(1): 71-76, ene.-feb. 2009. tab
Artículo en Español | LILACS | ID: lil-567729

RESUMEN

La inserción femenina a la educación superior en México y en gran parte del mundo, sucede a finales del siglo XIX y principios del XX. Los últimos treinta años han sido testigos de un aumento de la presencia femenina en las universidades, fenómeno estudiado como la “feminización de la matrícula”. Presentamos una breve reflexión del tema, con el fin de analizar de qué forma estas nuevas condiciones en el acceso a la educación se reflejan en la inserción de las mujeres en el ámbito científico. Repasamos el tema de la recomposición matricular, la segregación por áreas de estudio, tanto de varones como de mujeres, la participación a nivel posgrado (especialidad, maestría y doctorado) e indagamos la proporción de mujeres en la ciencia. Mientras en la educación superior se habla de una proporción entre varones y mujeres de casi 50 a 50 y en algunas áreas se ha llegado a reportar mayor presencia femenina, en el ámbito de investigación científica las mujeres apenas representan 30%. Esto responde en gran medida a condiciones estructurales en las que aún prevalece la dificultad de las mujeres para acceder a territorios de mayor jerarquía que han sido preponderantemente masculinos.


The participation of women in higher education in Mexico took place in the late 19th and early 20th century. The rise of women's enrollment in universities known as the [quot ]feminization of enrollment[quot ] occurred in the last thirty years. In this review we analyze how the new conditions that facilitated better access to higher education are reflected in the inclusion of women in science. We include an overview of the issues associated with a change in the demographics of enrollment, segregation of academic areas between men and women and participation in post graduate degrees. We also review the proportion of women in science. While in higher education the ratio between male and women is almost 50-50 and in some areas the presence of women is even higher, in the field of scientific research women account for barely 30% of professionals. This is largely due to structural conditions that limit the access of women to higher positions of power that have been predominantly taken by men.


Asunto(s)
Historia del Siglo XIX , Historia del Siglo XX , Ciencia/educación , Ciencia/historia , Mujeres/educación , Mujeres/historia , México
18.
Gac. méd. Méx ; 138(6): 533-546, Nov.-Dec. 2002.
Artículo en Español | LILACS | ID: lil-334528

RESUMEN

Neurologic diseases have important social and economic repercussions. The economic cost related to medications, caretakers, and therapists is evident, as well as the impact the disease may cause on the family. Epilepsy is the most frequent cause of medical care at the out-patient service of the Manuel Velasco Sußrez National Institute of Neurology and Neurosurgery (NINN), in Mexico City and the estimated annual prevalence of this disease is 5.9 per 1,000 inhabitants. Parkinson's disease, the most representative of movement disorders, affects 20 of the populating aged > 65 years. Depression and dementia are complex and heterogeneous neuropsychiatry disorders, representing the fifth cause of morbility after accidents, cardiovascular disease, liver cirrhosis and diabetes mellitus. During the last decades, encephalic trauma has been the first cause of mortality: among brain tumors, glioblastomas have the greatest impact. Among infectious disease of the central nervous system (CNS), which are relatively infrequent as compared to gastrointestinal or respiratory infections; viral encephalitis, AIDS-associated toxoplasmosis, and tuberculous meningitis are the most frequent discharge diagnoses at the NINN. The need for a national registration system of neurologic diseases is unquestionable. Such a system would provide accurate data regarding the magnitude of problems related with such disease and help design adequate care and prevention programs.


Asunto(s)
Humanos , Enfermedades del Sistema Nervioso , Infecciones del Sistema Nervioso Central , Costo de Enfermedad , Demencia , Trastorno Depresivo , Neoplasias del Sistema Nervioso , Traumatismos del Sistema Nervioso
19.
Arch. Inst. Nac. Neurol. Neurocir ; 9(2): 49-52, mayo-ago. 1994. tab
Artículo en Español | LILACS | ID: lil-188146

RESUMEN

La cisticercosis cerebral es una enfermedad pleomórfica y heterogénea. El diagnóstico se realiza mediante métodos de imagen y por estudios inmunológicos. La severidad de la reacción inflamatoria se mide a través de los estudios en LCR. Realizamos un estudio prospectivo en 44 pacientes con cisticercosis cerebral, con la finalidad de evaluar la elevación de la inmunoglobulina G en el LCR. Los pacientes con cisticercosis mixta, parenquimatosa y subaracnoidea (Grupo III) tuvieron un promedio mayor de inmunoglobulina G, que aquellas con cisticercosis parenquimatosa (Grupo II) o con calcificaciones (Grupo I) (p< 0.001). Pensamos que la IgG puede ser un parámetro clínico) más para valorar el curso de la enfermedad.


Asunto(s)
Cisticercosis/líquido cefalorraquídeo , Cisticercosis/diagnóstico , Diagnóstico por Imagen , Ensayo de Inmunoadsorción Enzimática , gammaglobulinas/inmunología , Líquido Cefalorraquídeo/parasitología
20.
Gac. méd. Méx ; 125(3/4): 105-11, mar.-abr. 1989. tab
Artículo en Español | LILACS | ID: lil-95318

RESUMEN

Se propone una nueva clasificación de las diversas formas de cisticercosis cerebral. Esta clasificación está basada fundamentalmente en la historia natural de la enfermedad y utiliza criterios pronosticos. Una clsaificación de esta naturaleza puede ser de gran utilidad para la toma de decisiones terapéuticas. De acuerdo con nuestros hallazgos la cisticercosis cerebral se puede dividir básicamente en formas benignas y malignas. La forma maligna por excelencia es la hidrocefalia. Las formas malignas requieren por lo general tratamiento quirúrgico y medicamentoso. En las formas benignas el tratamiento es básicamente sintomático medicamentoso. El praziquantel ha demostrado su utilidad únicamente en los pacientes con quistes pequeños parenquimatosos o subaracnoideos múltiples sin hidrocefalia


Asunto(s)
Humanos , Adulto , Masculino , Femenino , Cerebro/parasitología , Cisticercosis/clasificación , Cisticercosis/terapia , Teniasis/diagnóstico , Teniasis/terapia
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA